BridgeMD
New treatment option for Drain Output After Breast Reduction Surgery
Official title Effect of Intravenous and Topical Tranexamic Acid on Drain Output in Breast Reduction Surgery
ClinicalTrials.gov ID: NCT07131592
What this study is testing
What is IV TXA?
IV TXA is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for drain output after breast reduction surgery.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to evaluate whether tranexamic acid (TXA), a medication that helps reduce bleeding, can decrease fluid drainage after breast reduction surgery. Participants will be randomly assigned to receive either intravenous TXA or no TXA during surgery.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Adults aged 18 years or older
- Elective bilateral breast reduction
- Patient understands and is willing to participate in the study
- Patient willing to and capable of providing informed consent
You likely can't join if
- Age less than 18 years old
- Prior radiation to the breast
- Secondary/Revision breast reduction
- Known coagulopathy or bleeding disorders
- Intraoperative coagulopathy
- History of seizures
See the full eligibility criteria
- Adults aged 18 years or older
- Elective bilateral breast reduction
- Patient understands and is willing to participate in the study
- Patient willing to and capable of providing informed consent
- Age less than 18 years old
- Prior radiation to the breast
- Secondary/Revision breast reduction
- Known coagulopathy or bleeding disorders
- Intraoperative coagulopathy
- History of seizures
- Active smokers
- Allergy or contraindication to TXA
- Pregnant or breastfeeding patients
- Patient is unable or unwilling to complete the anticipated study follow-up
- Inability to understand the aims and objectives of the study
- Inability to or unwilling to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.